FUST MATTHEW K received a stock award from CRINETICS PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/22/2026ACC: 0001628280-26-044717
Director
Since Jul 2018
+15.65K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
15.65K acquired
Non-Derivative Transactions1
Common Stock
Direct
Shares
+5.92K
Price / share
—
Trade value
—
% of position
25.9%
6/18/2026
22.84K→28.76K
Total
Net shares
+5.92K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/18/2026 | A · Award | +5.92K | — | — | 25.9% | 22.84K | 28.76K |
| Total | +5.92K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Direct
Converts to
Common Stock
9.73K shares
Shares
+9.73K
Strike price
35.87
Held after
9.73K
Exercisable
—
6/18/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Direct | Common Stock9.73K shares | 6/18/2026 | A · Award | +9.73K | 35.87 | — | 9.73K |